Search:

Login | Subscribe

Home > Companies > Ark Therapeutics

Price	Market	Sector	Market Cap
38.50p (1.50p) 4.05%	LSE	Medicine and Biotech Research	£78.99m

Add to company folder | Print

Related Companies

AZM	11.25p	-6.25%
ASM	19.50p	-1.27%
ARA	6.50p	0.00%
AZN	2501.00p	-10.84%
CAT	p
DPH	391.75p	1.75%
GNS	640.00p	-3.03%
GSK	1190.00p	-4.26%
GSD	182.00p	3.41%
NTP	p
OXB	6.00p	-4.00%
PGN	p
PYM	6.25p	4.17%
PTI	45.00p	-2.17%
PRO	p
SHP	918.00p	-0.86%
SPH	20.00p	0.00%
SKP	151.00p	0.67%
MLS	p
THE	p
VEC	45.75p	1.67%
VER	3.60p	8.11%
XTL	p

Recent Articles

Ark wins trial approval	30/05/2008
Ark Therapeutics	06/11/2007
Runners and riders in the medical stakes	10/04/2006
Healthy demand for drug developers	30/03/2005
Drug floats drying up	02/08/2004
Tech watch - by Elliott Davis	02/06/2004

Recent Announcements

Interim Management Statement	13/11/2008
Product Launch	20/10/2008
Ark secures reimbursement for Neuropad	02/10/2008
Voting Rights and Capital	30/09/2008
Holding(s) in Company	17/09/2008
Interim Results	27/08/2008
Research Update	27/08/2008
Holding(s) in Company	26/08/2008
Voting Rights and Captial	01/08/2008
Holding(s) in Company	31/07/2008
More

Articles from the Sector

GW trims loss	19/11/2008
Asterand	18/11/2008
EU trial cheers Plethora	07/11/2008
IS Pharma	05/11/2008
Animalcare nurturing high-margin growth	03/11/2008
Phynova hails pre-clinical cheer	22/10/2008
e-Therapeutics	20/10/2008
Proximagen Neuroscience	16/10/2008
Tepnel expands with US deal	14/10/2008
Sinclair Pharma	03/10/2008
More

Financial History

Financial Year End	31/12/2003	31/12/2004	31/12/2005	31/12/2006	31/12/2007
Currency	GBP	GBP	GBP	GBP	GBP
Turnover	0.00	0.15	2.35	0.34	1.12
Operating Profit	-9.21	-15.07	-18.62	-20.94	-22.22
Pretax Profit	-8.75	-13.12	-16.78	-19.10	-20.02
Earnings After Tax	-8.10	-11.91	-15.14	-17.51	-18.18
Profit Available For Dividend	0.00	0.00	0.00	0.00	0.00
Ordinary Dividends	0.00	0.00	0.00	0.00	0.00
Retained Profit	-8.10	0.00	0.00	0.00	0.00
Shareholders Funds	9.26	48.42	34.40	49.51	68.07
Net Current Assets	7.60	0.00	0.00	0.00	0.00
Adjusted Earnings Per Share Undiluted	0.00	-0.10	12.00	-12.00	-11.00
Adj Earnings Per Share	0.00	-0.10	12.00	-12.00	-11.00
Dividend Per Share	0.00	0.00	0.00	0.00	0.00

Chart

Click here for interactive charting

Company Details
Address
Telephone
Fax
Advisers
Nominated Adviser
Nominated Broker
Solicitors
Auditors
Registrar

Company Data
Code	AKT
Sedol	GB00342517
Shares In Issue	205.158 m
Indices	TechmarkAllShare, Tech100, SmallCap
Entry on AIM
Interim Results
Final Results
Year End
Accounts Due
Int div payment
Fin div payment
Int net div per share
Fin net div per share
Probable CGT relief